AGENCY AGREEMENTAgency Agreement • November 25th, 2023
Contract Type FiledNovember 25th, 2023The undersigned, Stifel Nicolaus Canada Inc. ("SGMP") and Roth Canada, Inc. ("Roth" and together with SGMP, the "Agents"), as joint bookrunners and co-lead agents, understand that Mydecine Innovations Group Inc. (the "Corporation") proposes to sell, on a "best efforts" overnight marketed basis units of the Corporation (individually a "Unit" and collectively the "Units") at a price of $1.15 per Unit (the "Issue Price"), on the terms and subject to the conditions contained hereinafter. Each Unit consists of: (a) one Common Share (hereinafter defined) (individually a "Unit Share" and collectively the "Unit Shares"); and